Published online Sep 20, 2026. doi: 10.5662/wjm.115598
Revised: December 11, 2025
Accepted: March 4, 2026
Published online: September 20, 2026
Processing time: 263 Days and 0.2 Hours
Lower respiratory tract infections remain a major cause of morbidity and mortality among hospitalized patients. However, isolating organisms from respiratory samples often leads to diagnostic uncertainty due to the coexistence of colonizers, commensals, and contaminants. To address this challenge, this study employed a structured, stepwise exploratory model to differentiate true pa
To determine pathogen vs non-pathogen in lower respiratory tract isolates.
This prospective, longitudinal time-bound study was conducted over three months (August 2024 to October 2024) at a tertiary care center in Northern India. Adult patients (≥ 18 years) with positive lower respiratory tract samples were enrolled. Each isolate was independently classified by the treating clinician, microbiologist, and study investigator using a six-step clinical-microbiological algorithm that incorporated clinical signs, Sequential Organ Failure Assessment score trends, alternative infection sources, host factors, and outcome data. The final classification was determined by the investigator. Outcomes, including treatment response and mortality at 28 days, were compared across pathogen and non-pathogen groups.
Of the 145 included patients, 131 (90.3%) were classified as pathogens and 14 (9.7%) as non-pathogens. Cohen’s Kappa between investigator and microbiologist classifications was 0.28, indicating fair agreement. Among pathogen cases, 68 (51.9%) responded to treatment. In contrast, 12 of 14 non-pathogen cases (85.7%) were not treated, with favorable outcomes in most, and only one unrelated death (7.1%).
The structured clinico-microbiological model strongly correlates with treatment outcomes, making it useful for differentiating infection from colonization. Crucially, microbiological detection alone doesn’t determine pa
Core Tip: This prospective cohort study developed a structured clinico-microbiological model to distinguish true pathogens from colonizers in lower respiratory tract infections. Among 145 cases, 90% were identified as pathogens, with treatment outcomes aligning closely with the model’s classifications. The findings highlight that microbiological detection alone is insufficient for diagnosing infection - integrating clinical context and outcome data is crucial for rational antibiotic use and effective antimicrobial stewardship.